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Abstract
Background: This study investigated whether changing a tumor's oxygenation would alter tumor
metabolism, and thus uptake of 18F-FDG (fluorine-18 deoxyglucose), a marker for glucose
metabolism using positron emission tomography (PET).
Results: Tumor-bearing mice (squamous cell carcinoma) maintained at 37°C were studied while
breathing either normal air or carbogen (95% O2, 5% CO2), known to significantly oxygenate
tumors. Tumor activity was measured within an automatically determined volume of interest
(VOI). Activity was corrected for the arterial input function as estimated from image and blood-
derived data. Tumor FDG uptake was initially evaluated for tumor-bearing animals breathing only
air (2 animals) or only carbogen (2 animals). Subsequently, 5 animals were studied using two
sequential 18F-FDG injections administered to the same tumor-bearing mouse, 60 min apart; the
first injection on one gas (air or carbogen) and the second on the other gas. When examining the
entire tumor VOI, there was no significant difference of 18F-FDG uptake between mice breathing
either air or carbogen (i.e. air/carbogen ratio near unity). However, when only the highest 18F-FDG
uptake regions of the tumor were considered (small VOIs), there was a modest (21%), but
significant increase in the air/carbogen ratio suggesting that in these potentially most hypoxic
regions of the tumor, 18F-FDG uptake and hence glucose metabolism, may be reduced by increasing
tumor oxygenation.
Conclusion: Tumor 18F-FDG uptake may be reduced by increases in tumor oxygenation and thus
may provide a means to further enhance 18F-FDG functional imaging.
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18F-FDG (fluorine-18 deoxyglucose) has become widely
used as a radiolabeled marker for positron emission tom-
ography (PET) imaging of solid tumors. In some regions
of the body, the predictive power for identifying cancer
using 18F-FDG approaches 95% [1,2].
While altered glucose metabolism is a unique feature of
neoplastic growth, there are other factors associated with
the tumor micro-environment that are in marked contrast
to normal tissues. The vascular architecture in tumor tis-
sue is abnormal and differs greatly from normal tissues,
resulting in altered blood flow and the development of
tumor hypoxia. The presence of tumor hypoxia is thought
to represent a barrier for effective cancer treatment for
both radiation and chemotherapy [3-6]. Identifying
patients whose tumors contain hypoxic areas may there-
fore have an important role in tumor prognosis as well as
treatment approach and outcome. Currently, the ability to
identify and quantify tumor hypoxia is limited. The cur-
rent gold standard for measuring tissue oxygen concentra-
tion utilizes oxygen-sensitive electrodes, which measure
oxygen partial pressure (pO2) directly in tumor tissue.
Given the invasive nature of this technique, it is difficult
to access deep-seated tumors, and once assessed, it is dif-
ficult to distinguish between measurements made in
necrotic and viable regions [7]. Non-invasive techniques,
such as Overhauser-enhanced magnetic resonance imag-
ing (OMRI) [8] and electron paramagnetic resonance
imaging (EPRI) [9,10], are being evaluated to avoid the
obstacles encountered with the polarographic electrode.
Since non-invasive 18F-FDG/PET imaging is already
widely used in clinical facilities to identify malignant tis-
sue, we questioned whether this imaging modality might
be used to assess tumor hypoxia. Anaerobic metabolism
requires much more glucose to generate the same amount
of ATP as under aerobic metabolism. Given the hypoxic
nature of certain tumors, regions of tumor tissue are
known to resort to anaerobic glucose metabolism [11].
We hypothesize that experimentally increasing a tumor's
oxygen supply might enable the tumor to metabolize
more glucose aerobically, thus reducing 18F-FDG uptake.
To test this hypothesis, we have compared tumor 18F-FDG
uptake in tumor-bearing animals sequentially breathing
air (20.9% O2) and carbogen (95% oxygen, 5% CO2).
Carbogen breathing has been shown to markedly increase
the oxygenation status of tumors [8,12]. In addition, we
present data stressing the importance of maintaining nor-
mal body temperature in small animals undergoing 18F-
FDG/PET imaging.
Results
Figure 1 shows images from two of the pilot studies. Fig-
ure 1 (top) shows sagittal, coronal, and transaxial slices
through the tumor of a mouse (maintained at 37°C)
breathing air and a mouse breathing carbogen. Figure 1,
bottom, shows the time activity curve obtained from the
VOIs drawn around the entire tumor for a tumor-bearing
animal breathing air. The ordinate of the time activity
curve is the relative 18F-FDG activity concentration in the
tumor per mCi injected dose. Note that the decay cor-
rected FDG uptake curve is quite flat from 60 min until the
end of the study (130 min). This was true for all four mice
in the pilot study. Similar time activity curves were
obtained for animals breathing carbogen (data not
shown). Note also that the uptake in these two mice (one
on air and one on carbogen) was visually similar with
considerable heterogeneity of 18F-FDG uptake across the
tumor. Air versus carbogen comparisons could not be
made for these animals however, because data for the
mice in the pilot studies could not be corrected for possi-
ble differences in the arterial input function. In addition,
18F-FDG uptake would presumably have mouse-to-mouse
physiologic variation since different mice were used for air
and for carbogen, potentially masking true differences in
uptake caused by the nature of the ventilating gas. For
18F-FDG images (top) showing sagittal, coronal, and transax-ial slices through he tumor of a mouse (mai taine  at 37°C) breathing air and a different mouse br athing carbogenFigur  1
18F-FDG images (top) showing sagittal, coronal, and transax-
ial slices through the tumor of a mouse (maintained at 37°C) 
breathing air and a different mouse breathing carbogen. Both 
color scales set to the same maximum nCi/cc/injected-dose. 
Bottom: time activity curve obtained from the VOIs drawn 
around the entire tumor for a tumor-bearing animal breath-
ing air (animals breathing carbogen also resulted in similar 
curves, flat at late times).Page 2 of 9
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described above were undertaken. This second set of stud-
ies involved two sequential 18F-FDG injections in the
same mouse, 60 minutes apart, the first injection on one
gas (air or carbogen) and the second on the other gas. The
fact that the 18F-FDG time activity curves from the pilot
studies were flat, regardless of whether air or carbogen was
used, meant that in the two injection studies, we could
subtract the 18F-FDG activity present at the end of first 60
min from the activity following the second injection.
These two injection studies permitted sequential measure-
ment of air and carbogen uptake in the same tumor, and
permitted correction for possible differences in the arterial
input function.
Air to carbogen uptake ratios at normal temperature 
(37°C)
For each mouse we computed the ratio of the uptake
while breathing air to the uptake while breathing carbo-
gen, each corrected for the area under the input function
as per equation 2. A typical input function is shown in Fig-
ure 2, along with the late blood sample derived input
function. The measured input function was corrected
using the blood samples, as per equations 1–3. The ratio
of corrected tumor uptake while breathing air to corrected
tumor uptake while breathing carbogen, averaged over all
5 mice, did not differ significantly from 1.0 (ratio air/car-
bogen = 1.15, p = NS, Figure 3, squares). The ratio
remained not significantly different from unity whether
the VOI was drawn using a 30, 40 or 50% threshold, and
even when manually drawn VOIs encompassing the entire
tumor were used. Note from Figure 3 that the tumors of
four out of five mice exhibited air/carbogen ratios, all >1,
while one mouse deviated from the other 4, with a ratio
lower than unity. There was no a priori reason to exclude
the outlying animal, but doing so resulted in an air/carbo-
gen ratio, which did differ significantly from unity (air/
carbogen = 1.22, p < 0.01).
As shown in Figure 1 the SCC tumor exhibited considera-
ble heterogeneity in its uptake of 18F-FDG. We hypothe-
sized that regions of the tumor demonstrating
accentuated uptake of FDG might be exceptionally
hypoxic and so might respond differently to an increase in
the concentration of inspired oxygen as compared to
other tumor tissue. To test this hypothesis we analyzed
small VOI's (90% threshold) around regions of the
tumors demonstrating the greatest activity. Unlike the
data from the whole tumor, the uptake (corrected for
input function) for these small hot VOIs resulted in an air/
carbogen ratio that was consistent across all 5 mice, and
was significantly greater than unity (air/carbogen = 1.21,
p < 0.005, Figure 3, right). Again this result was insensitive
to the way the VOI was defined. The results held when the
VOI was based on either an 80% or 90% threshold, or
even if the maximum tumor value (averaged with its clos-
est neighboring pixels in all 3 dimensions) was used for
each tumor. We wished to visualize which pixels were
causing the difference in 18F-FDG tumor uptake for air ver-
sus carbogen breathing. Figure 4 shows 18F-FDG tumor
uptake images for three different animals who received
two 18F-FDG injections, one while breathing air and the
other while breathing carbogen. The first column shows
Air/carbogen ratios of tumor 18FDG uptake for whole tumor VOI (squares), as determined with the 3D region growing program usi g  30% threshold, and for th hottest part of the tum r (90% threshold)F gu e 3
Air/carbogen ratios of tumor 18FDG uptake for whole tumor 
VOI (squares), as determined with the 3D region growing 
program using a 30% threshold, and for the hottest part of 
the tumor (90% threshold). Tumor uptake ratios were cor-
rected using derived input function data as per equation 2 
and the 2nd injection activity was corrected for residual activ-
ity remaining as a result of the first injection.
Blood- and image-derived input functions for mice scanned at normal physiologic cor  body emperature (37°C)Figure 2
Blood- and image-derived input functions for mice scanned at 
normal physiologic core body temperature (37°C). Blood-
derived input functions were determined using blood sam-
ples drawn every 10 min, starting 30 min after 18FDG injec-
tion. Thus, the blood-derived input function curve begins at 
time = 30 min. Note that the blood samples always yielded 
lower activity concentration than the image data due to 
background activity, as per equation 1.Page 3 of 9
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column represents tumor 18F-FDG uptake for the animal
after switching to carbogen breathing (residual 18F-FDG
from initial injection subtracted). From these images it is
difficult to tell which pixels were causing the slight
decrease in tumor 18F-FDG uptake for animals breathing
carbogen. To clarify this, the third column shows the per-
centage increase in 18F-FDG uptake for air breathing ani-
mals versus carbogen breathing animals expressed as
100* (AirImage – CarbogenImage)/(mean counts in Air
tumor VOI). Ideally the denominator would have been
the air image, but due to image noise considerations the
mean value in the air tumor VOI (30% threshold) were
used instead. The data were normalized so that when the
tumor VOI was placed on the percentage increase image,
it gave a value equal to the value shown in the correspond-
ing point in Figure 3. Negative values are not displayed in
column 3. Instead the fourth column shows the (many
fewer) pixels in which carbogen exceeded air (i.e. the neg-
ative of the equation used for column 3).
Air to carbogen uptake ratios at low temperature (30°C)
When the core temperature of the mice was maintained at
30°C, an air/carbogen tumor ratio (averaged over all
mice) very much less than one was observed (mean air/
carbogen ratio = 0.47 ± 0.30; n = 2). Again, this result was
insensitive to the manner of VOI definition. Figure 5
shows 18F-FDG uptake during carbogen and air for a low
temperature mouse. It is quite clear that the tumor uptake
while breathing carbogen is markedly higher than the
uptake while breathing air. However, whereas the blood-
derived input functions from mice at normal physiologic
temperature (37°C) were highly reproducible across mul-
tiple mice, there was a large variability between blood-
derived input functions in the low-temperature mice.
Thus, one must interpret the data from mice not main-
tained at physiologic temperature with caution.
Discussion
Hypoxia in human tumors can significantly influence
treatment outcome and the aggressiveness of the tumor
[13]. This finding has led to considerable interest in non-
invasive means to assess the extent of hypoxia in tumors
prior to therapy, for example with MR (BOLD) imaging
[14,15]. Several studies have shown that tumor cell or
tumor 18F-FDG uptake is associated with hypoxia [16-18].
Glucose transporter (GLUT) receptor proteins and hexoki-
nase activity are elevated in tumors and thought to be
responsible for increased 18F-FDG tumor uptake com-
pared to normal tissues [19]. Hypoxia has been shown to
18F-FDG images showing sagittal, coronal, and transaxial slices through the tumor of a mouse maintained t 30°C given wo injections of 18F-FDG, th  first whil  breath ng air and the second w ile breath ng carbogenF gur 5
18F-FDG images showing sagittal, coronal, and transaxial 
slices through the tumor of a mouse maintained at 30°C 
given two injections of 18F-FDG, the first while breathing air 
and the second while breathing carbogen. Both images are 
displayed to the same scale, and are corrected for injected 
activity and residual activity produced by the first injection.
Sagittal 18FDG tumor uptake images for three mice (A, B, C) receiving two injections of 18FDG, one w il  the animal was brea hing air and the sec nd after the animal was switched toc rbogen bre thing, r vice-versa (a imals maintai ed at 37°C throughout the study)Fi ure 4
Sagittal 18FDG tumor uptake images for three mice (A, B, C) 
receiving two injections of 18FDG, one while the animal was 
breathing air and the second after the animal was switched to 
carbogen breathing, or vice-versa (animals maintained at 
37°C throughout the study). The first column shows the rel-
ative tumor 18F-FDG uptake for air breathing. The second 
column represents tumor FDG uptake for the animal after 
switching to carbogen breathing (residual 18F-FDG from ini-
tial injection subtracted). The first and second columns are 
shown with the same relative color scale. The third column 
shows the pixels in which air uptake exceeded carbogen 
uptake, expressed as 100*(AirImage - CarbogenImage)/
(mean counts in Air tumor VOI). Ideally the denominator 
would have been the air image, but due to image noise con-
siderations the normalization described was done instead. 
Negative values are not displayed in column 3. Instead the 
fourth column shows the (many fewer) pixels in which car-
bogen exceeded air (i.e. the negative of the equation used for 
column 3. Corrections were made for injected activity and 
for residual activity. The numeric values shown on the color 
bar apply only to columns 3 and 4.Page 4 of 9
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teins [16,17,20]. In the present study we examined
whether information concerning hypoxia could be gained
using 18F-FDG and PET imaging. This was considered pos-
sible since the hypoxic nature of most tumors forces
tumor glucose metabolism to utilize primarily glycolytic
pathways, rather than oxidative metabolism [11]. Very
large quantities of glucose are required to produce a given
amount of ATP via the glycolytic pathway compared to
the oxidative pathway, which supposedly accounts for
why many tumors have such high 18F-FDG uptake. We
hypothesized that by oxygenating the tumor (via breath-
ing carbogen), tumor glucose metabolism would begin to
have a significant oxidative component, requiring consid-
erably less glucose per ATP molecule produced. Thus, bet-
ter oxygenated tumors (i.e. tumors influenced by
breathing carbogen) should have less 18F-FDG uptake
than when in their usual, hypoxic state (i.e. while the ani-
mal is breathing air). To examine this possibility, 18F-FDG
uptake in tumors was examined in tumors when the
mouse was breathing air versus carbogen.
The SCC tumor used in the present study is known to be
quite hypoxic as determined by previous oxygen electrode
measurements in our laboratory [8]. Even though the
tumor is extremely hypoxic, there was no evidence of
necrosis in the tumors used in the present study (~1 cm
diameter). Carbogen breathing has been shown in numer-
ous studies to increase the oxygenation status of tumor-
bearing mice [8,21] and in patients [22-24]. Using the
same SCCVII tumor model, tumor size, and experimental
conditions with respect to the maintenance to core body
temperature as used in the present study, we have previ-
ously shown that carbogen breathing increases oxygena-
tion of the SCCVII tumor as measured by Eppendorf
oxygen electrodes [8,8]. In this study the mean tumor pO2
values for animals breathing air was 8.2 mm Hg, which
increased to a value of 19.8 for animals breathing carbo-
gen [8].
As mentioned above, the hypoxic nature of the SCC tumor
makes it likely that a large proportion of the tumor cells
would utilize glucose by anaerobic glycolysis, and so
exhibit enhanced 18F-FDG uptake. Indeed, we found glu-
cose utilization as measured by uptake of 18F-FDG to be
significant in the SCC tumor as evidenced by the tumor
images shown in Figure 1. The FDG uptake in the tumor
was particularly striking compared to the non-tumor bear-
ing leg where little to no uptake was observed (data not
shown). It was anticipated that increasing the oxygenation
of the tumor by carbogen breathing would lead to a shift
to aerobic metabolism producing much more ATP per
molecule of glucose, thereby decreasing the need for glu-
cose, and decreasing 18F-FDG tumor uptake. The results of
this study only partially supported this hypothesis. Air/
carbogen ratios for overall tumor 18F-FDG uptake were
not significantly different from unity. However, when
only the highest 18F-FDG uptake region of each tumor was
considered (perhaps the most hypoxic regions) the hypo-
thesis was supported. In these presumably metabolically
active regions, there was a small (21%) but significant
increase in air/carbogen uptake, suggesting reduced 18F-
FDG uptake under conditions of better oxygenation. The
lack of an air/carbogen difference for the whole tumor,
and the fairly small air/carbogen difference even for the
hottest part of the tumor might suggest that tumors are
"programmed" to burn glucose primarily in an anaerobic
fashion, regardless of their level of oxygenation. This
could be a potential survival mechanism for tissue des-
tined to grow in an anaerobic environment. This potential
explanation is of course speculative. Another factor which
could play a role is the potential vasodilatory properties of
carbon dioxide, although there is conflicting data
reported in the literature [24].
Changes in tumor FDG uptake (hot spots) when breath-
ing carbogen might add another dimension to 18F-FDG
functional imaging. While small, the 21% change in 18F-
FDG uptake in small regions may be giving information
similar and perhaps complimentary to that obtained by
the MRI based oxygen imaging is Blood Oxygen Level
Dependent (BOLD) MRI. For this imaging technique,
temporal changes in the ratios of deoxy- to oxyhemo-
globin can be monitored utilizing the contrast mecha-
nisms provided by deoxyhemoglobin to protons. With
this method, it is possible to examine changes in blood
flow and tumor oxygenation levels in response to carbo-
gen breathing versus air breathing [14,15]. The enhance-
ment observed in BOLD MRI images is typically only a
few percent. In contrast, the decrease in 18F-FDG tumor
uptake upon carbogen breathing in small regions of the
tumor in the present study was up to 21%, suggesting that
in these small regions tumor glucose metabolism is
altered as a result of increased perfusion and oxygenation.
Should this observation be correct, which will require fur-
ther validation, the added functional dimension to 18F-
FDG imaging afforded by carbogen breathing could be
useful to clinicians assessing treatment response, particu-
larly for radiation treatment.
Our results did not wholly agree with some previous stud-
ies that showed whole tumor 18F-FDG uptake increases in
more hypoxic conditions [25-28]. Our whole tumor
results gave an air/carbogen uptake ratio that did not dif-
fer significantly from unity. Only when VOIs were drawn
around the hottest part of our tumors were our findings
more consistent with these previous studies. The afore-
mentioned studies either examined a different tumor type
from our study (C3H mammary carcinomas) [25], or
examined the same tumor type (SCC), but in an in vitroPage 5 of 9
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account for the difference in our findings. Additionally,
this result could be due to differences in experimental
method, or due to the variability in our own results. Pre-
vious studies did not attempt to correct for potential dif-
ferences in input function. The lack of standardization
across animal PET studies, both in the means of determin-
ing reference input functions, as well as lack of consensus
regarding simpler procedures such as controlling animal
core temperature, might also explain this difference in
result. Future experiments with a greater number of mice,
using simultaneous blood sampling, would clarify the
results shown in Figure 3.
The ability to examine and quantify regions of greatest
change in 18F-FDG uptake, which is where a radiation
oncologist would presumably concentrate three-dimen-
sional conformal radiation dose painting, has significant
implications for cancer diagnosis and treatment. Future
studies could further test this phenomenon by shifting to
more hypoxic conditions, to see if 18F-FDG uptake
improves even more.
As an adjunct to our study, we examined the results
obtained when mice were allowed to drop core body tem-
perature to 30°C. Past work in our laboratory has demon-
strated that animal's core body temperature under
isoflurane anesthesia drops ten degrees in an average of 15
min [27]. We found that mice at this lower temperature
showed significantly greater 18F-FDG accumulation in car-
bogen than air environments. This could be due to relative
vasoconstriction in low temperature conditions, possibly
making 18F-FDG uptake flow limited in these circum-
stances. Adding carbogen to this low-temperature state
may improve blood flow, because vasculature responds to
the high partial pressure of oxygen by vasodilation.
Although this reasoning is speculative, our low tempera-
ture findings do point definitively to the necessity for
strict control of the mice's physiology and the need for
standardization across animal PET studies.
One strength of the present study was the ability to meas-
ure 18F-FDG uptake with air and carbogen breathing in
the same tumor. Previous studies have compared uptake
across different animals. Differences in tumor heterogene-
ity across mice potentially confound these results. Our
study controlled for this confounding variable. Further
studies would benefit from testing multiple tumor types,
as well as human tumors.
Conclusion
The ratio of 18F-FDG uptake in SCC tumors while breath-
ing air to that while breathing carbogen, did not differ sig-
nificantly from unity when the entire tumor was
considered, and when the animal's temperature was kept
at 37°C. When only the highest uptake regions of the
tumor were considered, however, there was a modest
(21%) but significant increase in the air/carbogen ratio.
This suggests that in these potentially most hypoxic
regions of the tumor, 18F-FDG uptake may be reduced by
increases in tumor oxygenation and thus may provide a
means to further enhance 18F-FDG functional imaging. As
a secondary finding, we note that when the mouse's tem-
perature was permitted to fall to 30°C (as occurs naturally
during isoflurane anesthesia), significant alterations in
18F-FDG metabolism were observed, making it clear that




Female C3H mice, produced by the National Cancer Insti-
tute Animal Production Area (Frederick, MD), were used
for this study. The mice were 7–9 weeks of age at the time
of experimentation and weighed between 20–30 grams.
All experiments were carried out under a protocol
approved by the National Cancer Institute Animal Care
and Use Committee, and were in compliance with the
Guide for the Care and Use Of Laboratory Animal Resource,
(1996) National Research Council. Tumors were grown in
the mice by a subcutaneous (s.c.) injection of a single-cell
suspension of 2 × 105 squamous cell carcinoma (SCCVII)
cells in the right hind leg. Tumors grew to a size of ~1.0
cm diameter 7–10 days after injection. Tumor volumes
were determined prior to PET scanning, by measuring
three orthogonal diameters using calipers. For all imaging
studies ~1 cm diameter tumors were used.
PET scanner
PET images were obtained with the ATLAS (Advanced
Technology Laboratory Animal Scanner), a dedicated
small animal PET scanner developed at NIH with an axial
field-of-view (FOV) of 2 cm, a transverse FOV of 6.8 cm
and an aperture of 8 cm [28-30].
The image data acquired with the ATLAS PET scanner were
reconstructed using the three-dimensional ordered subset
expectation maximization (OSEM) reconstruction algo-
rithm, including a model of the system resolution [31].
All reconstructions were performed on the NIH Biowulf
computer cluster, utilizing sixteen subsets and taking 10
iterations. Under these conditions, a spatial resolution of
1.6 mm full-width-at-half-maximum (FWHM) was
achieved.
PET scan experimental set-up
The mice were fasted at least 3 hours prior to injection of
18F-FDG. Each mouse was anesthetized with isoflurane
(induction; 2.0%, maintenance; 1.5%) carried by air at
750 ml/min and delivered via a nosepiece. An anestheticPage 6 of 9
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throughout the experiment. Once anesthesia was estab-
lished, further isoflurane was carried by either air (20.9%
oxygen) or carbogen (95% oxygen/5% CO2). In order to
inject18F-FDG intravenously (IV), a cannula was inserted
into a tail vein. The IV lines consisted of a 30 gauge 1/2"
needle inserted into one end of a 60 cm length of PE10
tubing (IntraMedic Polyethylene) (internal diameter =
0.28 mm; external diameter = 0.61 mm) and the needle of
another removed from the hub inserted into the opposite
end of the tubing. IV lines were filled with heparin (100
USP units/mL) prior to cannulation. To verify the integrity
of the line, a bolus of heparin was given prior to 18F-FDG
injection. A bladder catheter (PE10 tubing) was used to
collect urine output and a rectal temperature probe (FISO
Technologies Fiber Optic Temperature Gauge Model FOT
C-PEEK) was used to monitor and maintain core body
temperature. Once these procedures were completed the
mouse was immobilized in a jig that secured the feet. This
jig was inserted into a cylindrical Lucite chamber, fixed
with a port for the attachment of thermostat-controlled,
warm air circulator (Nikon Model ITC-32, Nikon Inc.
Japan) in order to maintain the mouse's core temperature.
The entire assembly was fixed to a computer-controlled
motorized gantry capable of precisely moving the animal
into the scanner. After core temperature of 37°C was
established, PET image collection was started, and a 100
μl bolus of 18F-FDG (~400 μCi in 0.9% saline) was
injected. The injected doses were recorded for each animal
imaged. Initial pilot studies were performed on 4 mice by
centering the tumor in the field-of-view prior to injection.
Two of these first mice were studied only with carbogen
and two only with air. For each mouse, a dynamic acqui-
sition of 5 min/frame was acquired for 90 min total. In
subsequent experiments each mouse was studied sequen-
tially on both air and carbogen. These sequential studies,
performed on an additional 5 mice were more complex,
each consisting of 5 phases. Initially, each animal was
anesthetized using either air or carbogen as the carrier gas
for the isoflurane (3 with air and 2 with carbogen). While
this gas was continuously administered, the scanner was
positioned at the level of the heart, and dynamic imaging
begun immediately prior to injection of 18F-FDG (12
frames/10 sec for 2 min, 6 frames/30 sec, followed by 45
frames/1 min), continuing for 50 min, in order to capture
an image-derived input function. The scanner was then
moved to the level of the tumor (the lower extremities),
and dynamic imaging (5 min/frame) resumed for an addi-
tional 40 min, while continuing to administer the same
mixture of isoflurane and either air or carbogen. At the
end of this acquisition, the carrier gas for isoflurane was
switched from air to carbogen, or vice versa, and the ani-
mal was left to equilibrate on the new gas mixture for 10
min. When the 10-minute equilibration period had
ended, the scanner was again moved to the level of the
heart and dynamic image collection commenced as
described above, beginning approximately 30 sec prior to
injection of a second bolus of 18F-FDG, first over the heart
and then over the tumor. All the studies described above
were performed while the mouse's body temperature was
kept at 37°C.
An additional 2 mice were studied using this same two
injection methodology but while their body temperature
was kept at 30°C. We have previously shown that C3H
SCCVII tumor-bearing animals placed on isoflurane expe-
rience an approximate 7°C decrease in core body temper-
ature 15 min after initiation of isoflurane [27]. To conduct
low temperature studies animals were prepared as
described above and were administered isoflurane with-
out temperature control until the core body temperature
dropped to 30°C at which point the warm air circulator
was adjusted to maintain a core body temperature of
30°C. This temperature was maintained throughout the
two injection study.
Blood sampling
After anesthetizing the mouse with isoflurane carried by
medical air (1.5%, 700 mL/min), the skin and integument
over the right or left ventral surface of the neck was cut
with surgical scissors and the cleidomastoideus and ster-
nomastoideus muscles were dissected to expose the left
external jugular vein, removing fat and/or cauterizing
peripheral vessels to minimize blood loss. A cannula, like
that described previously for tail vein cannulation, was
then inserted into the external jugular vein and fixed in
place with Vetbond tissue adhesive. A junction was made
by soldering a 30 G 1/2" needle into a 23 G 1" needle. The
30 G 1/2" needle end could be inserted into the end of the
central line, while the 23 G 1" needle end could then be
inserted into a small piece of PE50 tubing, into which a 10
μL Hamilton syringe could be inserted for a more precise
collection of blood. After administering 18F-FDG (~400
μCi, 100 μl) bolus, 10 μL of blood were drawn from the
central line every ten minutes for one hour. Each blood
sample was then diluted in 1 mL of saline, and its activity
was read in a Cobra II AutoGamma scintillation counter.
Image-derived and blood-draw derived input functions
It is possible that the input function (the concentration of
arterial 18F-FDG as a function of time) would change
depending on whether the mouse was breathing air or car-
bogen. The area under the input function is a measure of
the amount of 18F-FDG available for the tumor to metab-
olize. In order to compare air and carbogen 18F-FDG
uptakes, the ratio of mean air to carbogen uptake in the
tumor volume of interest (VOI) was computed, normaliz-
ing by the integral of the input function from time zero up
to the time of the measurement of uptake. The input func-Page 7 of 9
(page number not for citation purposes)
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described below.
PET images at early time points revealed a large vessel dor-
sal and/or caudal to the heart. Comparison with CT
images indicated that the vessel was the inferior vena cava,
but this could not be determined with absolute certainty
due to possible small mis-registrations between PET and
CT. A strict determination of whether the vessel was arte-
rial or venous was thought unnecessary, apart from any
first transit uptake by the lung (known to be low), espe-
cially since the bolus was slow compared to the expected
rapid cardiac transit times [32].
To determine a measured blood time activity curve, Am(t),
using the major blood vessel, regions of interest were
drawn around this vessel at several transaxial levels to
determine the relative mean activity concentration in the
vessel over time. Only relative concentrations could be
determined because the diameter of this vessel was
thought to be small compared to the spatial resolution of
the scanner, making partial volume effects important. Fur-
thermore, tissues adjacent to the vessel could have poten-
tially contaminated the activity measured in the region of
interest [33]. Corrections for these effects were made in
the following way. A square region of interest (ROI), 2.8
mm on a side and encompassing the aorta was drawn and
used to generate an aortic time activity curve. Two concen-
tric rectangles were then drawn around this first ROI (7.3
mm and 9.6 mm on a side) and a background region was
obtained by subtracting the smallest ROI from the largest
ROI. Another time activity curve was created from this
background region in order to estimate the background
activity, B(t). It was assumed that the measured input
function, Am(t) was equal to some combination of the
true input function, At(t), and the background activity,
B(t):
Am(t) = a* At(t) + b*B(t). equation 1
The constant "a" is less than unity because some of the
counts blur out of the vessel region of interest due to the
partial volume effect. Similarly "b" represents blurring of
background counts into the vessel's region of interest. B(t)
was only a negligibly small fraction of A(t) until late times
(> 4 min) so the correction was only important at late
times.
Since we were only interested in estimating the ratio of the
blood input functions as a result of two different physio-
logical challenges, air and carbogen breathing, we did not
need to correct the input functions for "a" because the size
and placement of the ROI was identical in each case:
Thus, we only needed to correct the input function for
background contamination. Four venous blood samples
were drawn from 30–60 min post injection. These sam-
ples were thought to be at late enough times so that
venous activity concentrations would be nearly identical
to arterial concentrations, so At(t) = Blood(t) at late times.
This was confirmed by the very slow variation of Am(t)
versus t at these times. Therefore, for each dataset, air or
carbogen, the scaling factor b was obtained considering
the true blood activity derived from the blood draws at
late time, the actual measured input function and the
background activity:
To make the correction more robust, 4 time points were
considered in order to estimate b.
For logistical reasons, blood samples could not be drawn
from the same mouse. Therefore a cohort of 6 mice of the
same age, size, and tumor development as the mice
imaged were injected with the same volume of FDG, and
each breathed either air or carbogen under the same con-
ditions as the imaged mice. The time activity curves for all
mice (n = 3, air; n = 3, carbogen) were normalized by the
activities of injected 18F-FDG and the curves were fit tem-
porally with a bi-exponential function. These fitted nor-
malized blood samples were then used in the equation 3
to compute b. Once b was determined for each imaged
mouse, the true arterial ratio between air and carbogen
could be computed from equation 2.
Volumes of interest
Volumes of interest around the whole tumor were defined
using a semi-automatic, three-dimensional, threshold
based, region-growing algorithm (MedX, Sensor Systems
Inc). The threshold was based on a percentage of the aver-
age maximum intensity in the tumor. Average maximum
intensity was defined as the maximum pixel in the tumor
averaged with neighboring pixels in a 0.5625 mm radius
sphere, to reduce statistical noise. A 30% threshold gener-
ated a VOI that visually included the entire tumor, but
VOIs using other thresholds were also studied.
The very small in-plane mis-registrations of certain mice
that occurred between the air and the carbogen measure-
ments were corrected by maximizing the 3D correlation
between the two image sets (FLIRT linear registration tool;
Image Analysis group, Oxford University). The final series
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during air breathing. Image data outside the tumor were
not used for registration. The 3D-to-3D registration was
performed using six degrees of freedom (rigid body), with
3 translations and 3 rotations. After proper normalization
for input function, the air data set was then subtracted
from the carbogen data set, and the alignment of tumor
signals was judged by eye. Although not used for align-
ment, the femoral vessels also appeared to be present in
each data set, and the signal in those regions was zero after
the subtraction, lending support to accurate registration.
Registration resulted in at most a 2 mm total displacement
in the region of the tumor.
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